Atra stock forecast.

ATRA stock had an impressive performance on September 26, 2023, with the potential for significant growth in the coming months. According to CNN Money, seven analysts have provided 12-month price forecasts for Atara Biotherapeutics Inc, with a median target of $20.00.

Atra stock forecast. Things To Know About Atra stock forecast.

Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Mustang Bio Inc have a median target of 16.50, with a high estimate of 25.00 and a low estimate of 8.00. The median ...The ATRA stock price is -767.69% off its 52-week high price of $5.64 and 69.23% above the 52-week low of $0.20. If we look at the company’s 10-day average daily trading volume, we find that it stood at 5.67 million shares traded. The 3-month trading volume is 3.89 million shares. The consensus among analysts is that Atara Biotherapeutics Inc ...S Stock 12 Months Forecast. Based on 20 Wall Street analysts offering 12 month price targets for SentinelOne in the last 3 months. The average price target is $18.97 with a high forecast of $23.00 and a low forecast of $16.50. The average price target represents a 5.86% change from the last price of $17.92.THOUSAND OAKS, Calif.-- (BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its …

Get the latest Atara Biotherapeutics Inc (ATRA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. This rich reservoir of information aids in informed decision-making, blending historical data with future predictions to paint a holistic picture of stock performance trajectories. …

About. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result ...

ASTS Earnings Forecast. Next quarter’s earnings estimate for ASTS is -$0.21 with a range of -$0.21 to -$0.21. The previous quarter’s EPS was -$0.24. ASTS beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 61.91% of the time in the same period.Stock Price Forecast The 9 analysts offering 12-month price forecasts for Science Applications International Corp have a median target of 115.00, with a high estimate of 130.00 and a low estimate ... This year’s forecast. As for the 2023 expectation, City analysts currently think AstraZeneca will reward investors with a payout of $3.06 per share. That would represent a third consecutive ...About the Tesla, Inc. stock forecast. As of 2023 December 01, Friday current price of TSLA stock is 232.950$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Tesla stock price as been showing a rising tendency so we believe that similar market segments were very popular …Nov 23, 2023 · High Growth Earnings: ATRA is forecast to remain unprofitable over the next 3 years. Revenue vs Market: ATRA's revenue (44.8% per year) is forecast to grow faster than the US market (8.1% per year). High Growth Revenue: ATRA's revenue (44.8% per year) is forecast to grow faster than 20% per year.

Tilray Stock Forecast 12-10-2023. Forecast target price for 12-10-2023: $ 1.86. Negative dynamics for Tilray shares will prevail with possible volatility of 11.482%. Pessimistic target level: 1.72. Optimistic target level: 1.94.

Atara Biotherapeutics Stock Forecast 10 Nov. Presumably, on 11/10/2023, the price of shares will be in the range of $1.31 - $1.36. A $0.05 range width can provide 3.98% volatility. The weighted average price of this range is at $1.34, which is $0.00 lower than the previous day's weighted average price.

About. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result ... 15 analysts have issued 12-month price objectives for Boeing's stock. Their BA share price targets range from $200.00 to $300.00. On average, they expect the company's stock price to reach $249.38 in the next year. This suggests a possible upside of 13.4% from the stock's current price.KPRX Stock 12 Months Forecast. $2.75. (347.15% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Kiora Pharmaceuticals in the last 3 months. The average price target is $2.75 with a high forecast of $3.50 and a low forecast of $2.00. The average price target represents a 347.15% change from the last price of $0.62.Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Mustang Bio Inc have a median target of 16.50, with a high estimate of 25.00 and a low estimate of 8.00. The median ...Aug 8, 2023 · Atara Biotherapeutics (ATRA) delivered earnings and revenue surprises of -4.62% and 71.48%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

The Gevo stock price gained 1.72% on the last trading day (Friday, 24th Nov 2023), rising from $1.16 to $1.18. During the last trading day the stock fluctuated 4.35% from a day low at $1.15 to a day high of $1.20. The price has risen in 7 of the last 10 days and is up by 11.32% over the past 2 weeks. Volume fell on the last day by -2 million ...Atara Biotherapeutics Stock Forecast. Is Atara Biotherapeutics Stock Undervalued? The current Atara Biotherapeutics [ ATRA] share price is $0.65. The Score for ATRA is 19, which is 62% below its historic median score of 50, and infers higher risk than normal. ATRA is currently trading in the 10-20% percentile range relative to its historical ... About the Tesla, Inc. stock forecast. As of 2023 December 01, Friday current price of TSLA stock is 232.950$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Tesla stock price as been showing a rising tendency so we believe that similar market segments were very popular …The current average ATRA price target, as estimated by these analysts, is $3.00. The predictions for the future ATRA stock price range from a low of $3.00 to a high of $3.00, highlighting the variability of market expectations for ATRA.Atara Biotherapeutics (ATRA) Slumps 57% in a Month: Here's Why. Atara's (ATRA) shares fell after a phase II study evaluating its multiple sclerosis therapy did not meet its primary …

People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.16.19 0.00 0.00% The 7 analysts offering 1 year price forecasts for ATRA have a max estimate of — and a min estimate of —. Analyst rating Based on 9 analysts giving stock …

Nov 29, 2023 · So, when comparing one stock to another in a different industry, it's best make relative comparisons to that stock's respective industry values. -6,390.31% -223.52% Nov 2, 2023 · On November 2, 2023, Atara Biotherapeutics Inc (ATRA) experienced a significant surge in its stock performance following positive price forecasts from analysts. According to data from CNN Money, seven analysts have offered 12-month price forecasts for ATRA, with a median target of $19.00. During the last day, the stock moved $0.1000 between high and low, or 1.40%. For the last week, the stock has had daily average volatility of 1.24% . Our recommended stop-loss: $6.83 (-5.75%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 19 days ago.)Atara Biotherapeutics, Inc. Common Stock (ATRA) Stock Price, Quote, News & History | Nasdaq MY QUOTES: ATRA Edit my quotes Atara Biotherapeutics, Inc. Common …The consensus price target of analysts on Wall Street is $10.89, which implies an increase of 97.34% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $1.00 and $28.00 respectively. As a result, ATRA is trading at a discount of -9555.17% off the target high and -244.83% off the low.Nov 30, 2023 · What is the current Price Target and Forecast for Atara Biotherapeutics (ATRA) Atara Biotherapeutics (ATRA) (Delayed Data from NSDQ) $0.51 USD +0.03 (6.14%) Updated Nov 17, 2023 04:00 PM ET...

SmartAssetPaid Partner. Find real-time T - AT&T Inc stock quotes, company profile, news and forecasts from CNN Business.

The MacroGenics stock price gained 1.49% on the last trading day (Friday, 24th Nov 2023), rising from $7.39 to $7.50. During the last trading day the stock fluctuated 4.46% from a day low at $7.35 to a day high of $7.68. The price has been going up and down for this period, and there has been a 14.5% gain for the last 2 weeks.

21 nov 2023 ... On the technical perspective front, indicators give ATRA a short term outlook of 100% Sell on average. Looking at the stock's medium term ...The forecast for beginning of April 8450. Maximum value 8638, while minimum 7660. Averaged FTSE value for month 8224. Value at the end 8149, change for April -3.56%. NIO Stock Forecast 2023, 2024, 2025. More Stock Forecasts... FTSE 100 predictions for May 2025. The forecast for beginning of May 8149. Maximum value …16 analysts have issued twelve-month price objectives for Alibaba Group's shares. Their BABA share price targets range from $90.00 to $150.00. On average, they expect the company's share price to reach $129.20 in the next year. This suggests a possible upside of 74.6% from the stock's current price.Stock Price Forecast. According to 6 stock analysts, the average 12-month stock price forecast for ATRA stock stock is $12.15, which predicts an increase of …Stock Price Forecast. The 3 analysts offering 12-month price forecasts for Akebia Therapeutics Inc have a median target of 4.00, with a high estimate of 5.00 and a low estimate of 4.00. The median ...Plug Power Stock Forecast 2030-2034. In this period, the Plug Power price would rise from $19.25 to $24.13, which is +25%. Plug Power will start 2030 at $19.25, then soar to $19.65 within the first half of the year, and finish 2030 at $20.06. It is about +402% from today. Plug Power Stock Price Forecast 2023-2024.3 Wall Street research analysts have issued twelve-month target prices for Trulieve Cannabis' stock. Their TCNNF share price targets range from $6.00 to $132.00. On average, they anticipate the company's stock price to reach $42.92 in the next year. This suggests a possible upside of 693.3% from the stock's current price.Atara Biotherapeutics stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Atara Biotherapeutics analysts is $ 14.72 . Today 200 Day Moving Average is the resistance level ( 2.335 $).Earnings Date. Feb 06, 2024 - Feb 12, 2024. Forward Dividend & Yield. N/A (N/A) Ex-Dividend Date. N/A. 1y Target Est. 3.94. Fair Value is the appropriate price for the shares of a company, based ...2.46%. $74.52M. Immunogen Inc. 6.11%. $4.3B. ATRA | Complete Atara Biotherapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Mizuho Securities analyst Salim Syed has maintained their bullish stance on ATRA stock, giving a Buy rating on September 26.. Salim Syed’s rating of Atara Biotherapeutics as a Buy is driven by a ...The average Bit Digital stock price prediction forecasts a potential upside of 55.04% from the current BTBT share price of $2.58. What is BTBT's forecast return on equity (ROE) for 2023-2024? (NASDAQ: BTBT) forecast ROE is N/A, which is considered weak.

Plug Power Stock Forecast 2030-2034. In this period, the Plug Power price would rise from $19.25 to $24.13, which is +25%. Plug Power will start 2030 at $19.25, then soar to $19.65 within the first half of the year, and finish 2030 at $20.06. It is about +402% from today. Plug Power Stock Price Forecast 2023-2024.4 Wall Street research analysts have issued twelve-month price objectives for Ginkgo Bioworks' shares. Their DNA share price targets range from $1.25 to $3.00. On average, they anticipate the company's stock price to reach $2.25 in the next year. This suggests a possible upside of 58.5% from the stock's current price.Atara Biotherapeutics Stock Forecast, "ATRA" Share Price Prediction Charts Is "Atara Biotherapeutics Inc" a Good Investment? Current price today: 0.650 USD (+2.331%) …In today’s fast-paced business environment, accurate forecasting is crucial for making informed decisions and staying ahead of the competition. One powerful tool that can help you achieve this is a forecasting Excel template.Instagram:https://instagram. day trader platformsfree retirement appetf for nasdaqjohson control All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange ...Sep 19, 2023 · Atara Biotherapeutics Inc (ATRA) stock experienced a significant surge today following the release of optimistic price forecasts from analysts. With a median target of $20.00, the stock is expected to witness a staggering 1,165.82% increase from its last closing price of $1.58. insurance for airplanesstock tyson 23 brokers have issued 1 year price targets for Advanced Micro Devices' shares. Their AMD share price targets range from $80.00 to $200.00. On average, they expect the company's share price to reach $134.77 in the next twelve months. This suggests a possible upside of 11.0% from the stock's current price.Sep 19, 2023 · Atara Biotherapeutics Inc (ATRA) stock experienced a significant surge today following the release of optimistic price forecasts from analysts. With a median target of $20.00, the stock is expected to witness a staggering 1,165.82% increase from its last closing price of $1.58. home depot movers 16 sept 2020 ... See if the stock goes on to build a promising consolidation that could kick off a new price move. Atara Biotherapeutics (ATRA).16 equities research analysts have issued twelve-month price targets for SoFi Technologies' stock. Their SOFI share price targets range from $3.00 to $15.00. On average, they anticipate the company's share price to reach $8.78 in the next year. This suggests a possible upside of 12.1% from the stock's current price.